Welcome to Foukakis Lab

We are a dynamic, multidisciplinary research group at Onc-Pat, KI, consisting of clinicians, bioinformaticians, epidemiologists, biostatisticians, AI engineers and molecular biologists. We work with clinical studies of breast cancer and use molecular analyses of tumor tissue or blood aiming to understand how treatment resistance occurs and to identify novel treatment predictive biomarkers.

We aim to: (a) understand breast cancer, by uncovering the biological, molecular, and clinical mechanisms that drive treatment resistance and disease progression; and (b) to advance precision oncology, by discovering, developing and validating novel biomarkers, through hypothesis-driven and data-driven tools that can guide personalized treatment and improve patient outcomes.

To achieve these goals, we integrate clinical research, molecular biology, bioinformatics, and artificial intelligence in a truly multidisciplinary environment. We develop and apply cutting-edge methods — from spatial in situ analyses and single-cell omics to digital pathology and multimodal AI — to reveal the hidden patterns that shape cancer behavior and therapy response.

We are located at Bioclinicum, Karolinska Institutet, Solna, at the heart of the vibrant city of Stockholm. Embedded in a leading clinical and translational research environment, we collaborate closely with world-class groups in oncology, molecular biology, bioinformatics, and AI-driven precision medicine. We actively participate in EU-funded research projects, and maintain collaborations with leading institutions in Europe, US and worldwide. We also travel frequently to international conferences and meetings (ESMO, ASCO, SABCS, etc.), where we are always happy to connect, collaborate, and exchange ideas with colleagues and fellow researchers who share our passion for translational cancer science.

We are looking for exceptional new PhD students and Postdocs to join the team (more info) !